Literature DB >> 2860220

The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice.

M N Azmin, A T Florence, R M Handjani-Vila, J F Stuart, G Vanlerberghe, J S Whittaker.   

Abstract

Non-ionic surfactant vesicles (niosomes) prepared from a non-ionic surfactant, cholesterol and dicetyl phosphate and containing methotrexate (MTX) have been administered to mice. Given intravenously the niosomes prolong the levels of MTX in the blood, large amounts of the drug being taken up by the liver. There was also an increased uptake of MTX into the brain, perhaps due to an effect of the niosome components on the permeability of the blood brain barrier. Absorption of the drug from the gastrointestinal tract following oral ingestion, appeared to be increased at some doses; most of the entrapped MTX was taken up by the liver, but uptake of MTX into the brain was also increased. The metabolic profile of the drug is altered by the niosomes which appear to prevent the rapid formation of 7-hydroxy methotrexate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860220     DOI: 10.1111/j.2042-7158.1985.tb05051.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  26 in total

1.  SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes.

Authors:  A I Blazek-Welsh; D G Rhodes
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

2.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

3.  The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin.

Authors:  J M Brewer; J Alexander
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

4.  Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.

Authors:  Ismail A Attia; Sanaa A El-Gizawy; Medhat A Fouda; Ahmed M Donia
Journal:  AAPS PharmSciTech       Date:  2007-12-14       Impact factor: 3.246

5.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

6.  Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment.

Authors:  Nitin Mali; Sharad Darandale; Pradeep Vavia
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

7.  Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.

Authors:  Amit Verma; Ankit Jain; Ankita Tiwari; Shivani Saraf; Pritish Kumar Panda; Sanjay K Jain
Journal:  AAPS PharmSciTech       Date:  2021-01-03       Impact factor: 3.246

8.  Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.

Authors:  Deepak Kumbhar; Preeti Wavikar; Pradeep Vavia
Journal:  AAPS PharmSciTech       Date:  2013-07-02       Impact factor: 3.246

9.  New sterically stabilized vesicles based on nonionic surfactant, cholesterol, and poly(ethylene glycol)-cholesterol conjugates.

Authors:  S Beugin; K Edwards; G Karlsson; M Ollivon; S Lesieur
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

10.  Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouse.

Authors:  I F Uchegbu; J A Double; J A Turton; A T Florence
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.